Novo Nordisk accused Eli Lilly of falsely claiming that its weight-loss medicines are more effective, in a U.S. lawsuit, ...
July 21 (Reuters) - Novo Nordisk accused Eli Lilly of falsely claiming that its weight-loss medicines are more effective, in ...
Business Insider Africa on MSN
Africa’s most developed pharmaceutical market reviews 12 Ozempic generics as drugmakers target Novo Nordisk’s dominance
A major battle over the cost of blockbuster diabetes and weight-loss drugs is unfolding in Africa as South Africa reviews 12 ...
In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers ...
In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers ...
By Nqobile Dludla JOHANNESBURG, July 21 (Reuters) - South Africa's health regulator is reviewing 12 applications for generic ...
Novo Nordisk’s Ozempic is becoming a generic term for weight-loss drugs, despite legal efforts to protect its trademark. As competitors gain popularity, the risk is that “Ozempic” will lose its brand ...
For Medicare beneficiaries prescribed a glucagon-like petide-1 (GLP-1) receptor agonist, eligibility rules are far from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results